Isolation and long-term culture of gallbladder epithelial cells from wild-type and CF mice

1997 ◽  
Vol 33 (2) ◽  
pp. 104-109 ◽  
Author(s):  
Rahul Kuver ◽  
Christopher Savard ◽  
Toan D. Nguyen ◽  
William R. A. Osborne ◽  
Sum P. Lee
1994 ◽  
Vol 266 (2) ◽  
pp. L148-L155 ◽  
Author(s):  
H. Blau ◽  
S. Riklis ◽  
V. Kravtsov ◽  
M. Kalina

Cultured alveolar type II cells and pulmonary epithelial (PE) cells in long-term culture were found to secrete colony-stimulating factors (CSF) into the medium in similar fashion to alveolar macrophages. CSF activity was determined by using the in vitro assay for myeloid progenitor cells [colony-forming units in culture (CFU-C)]. Both lipopolisaccharide (LPS) and interleukin-1 alpha (IL-1 alpha) were found to upregulate the secretion 6.5- to 8-fold from alveolar type II cells and macrophages. However, no stimulatory effect of these factors was observed in PE cells that release CSF into the medium constitutively, possibly due to the conditions of long-term culture. The CSF activity was partially neutralized (70% inhibition) by antibodies against murine granulocyte/macrophage (GM)-CSF and IL-3, thus indicating the presence of both GM-CSF and IL-3-like factors in the CSF. However, the presence of other cytokines in the CSF is highly probable. Surfactant-associated protein A (SP-A), which is known to play a central role in surfactant homeostasis and function, was also found to upregulate secretion of CSF (at concentrations of 0.1-5 micrograms/ml) from alveolar type II cells and macrophages. Control cells such as rat peritoneal macrophages, alveolar fibroblasts, and 3T3/NIH cell line could not be elicited by SP-A to release CSF. The results are discussed in relation to the possible participation of the alveolar epithelial cells in various intercellular signaling networks. Our studies suggest that alveolar type II cells and SP-A may play an important regulatory role in the modulation of immune and inflammatory effector cells within the alveolar space.


2019 ◽  
Vol 30 (14) ◽  
pp. 1641-1644
Author(s):  
Jamie L. Lahvic ◽  
Iswar K. Hariharan

Cancer treatments have, in general, targeted the cancer cell itself. This approach has often been unsuccessful in the long term, especially for solid tumors. Even targeted therapies based on sequencing cancer genomes can be thwarted by genetic heterogeneity within tumors. Furthermore, genomic instability in cancer cells accelerates the generation of variants that are resistant to the treatment. Immunotherapies and anti-angiogenic treatments, which target the tumor-interacting and tumor-adjacent cells, have overcome some of these challenges, suggesting that other methods that target wild-type cells could be valuable in arresting tumor progression. Studies in Drosophila have uncovered mechanisms by which cells within an epithelium can react to neighboring cells that have genetic differences, resulting in the elimination of one population at the expense of another. Some of these mechanisms are now known to be conserved in mammals. The possibility of harnessing such mechanisms to empower normal epithelial cells to eliminate their precancerous neighbors before they develop into fully fledged cancers is an area of research that merits more attention.


1996 ◽  
Vol 64 (2) ◽  
pp. 161-169 ◽  
Author(s):  
Clifford W. Deveney ◽  
Leslie Rand-Luby ◽  
Michael J. Rutten ◽  
Cheryl A. Luttropp ◽  
Wendy M. Fowler ◽  
...  

2009 ◽  
Vol 50 (6) ◽  
pp. 2716 ◽  
Author(s):  
Xiaoli Ma ◽  
Shigeto Shimmura ◽  
Hideyuki Miyashita ◽  
Satoru Yoshida ◽  
Miyuki Kubota ◽  
...  

1988 ◽  
Vol 24 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Brenda L. Schumann ◽  
Terence E. Cody ◽  
Marian L. Miller ◽  
George D. Leikauf

Cornea ◽  
2002 ◽  
Vol 21 (2) ◽  
pp. 215-219 ◽  
Author(s):  
Hin-Fai Yam ◽  
Dennis Shun-Chiu Lam ◽  
Chi-Pui Pang

Sign in / Sign up

Export Citation Format

Share Document